Clinical Trials
Light Chain Bioscience Successfully Completes Factor VIII Mimetic Bispecific...
Light Chain Bioscience has achieved a milestone and received a payment under its research and collaboration agreement with Takeda Pharmaceutical. The milestone was achieved upon...
Clinical Trials
Chiesi Group Announces Establishment of New Global Rare Diseases...
Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced the formation of Chiesi Global Rare Diseases, a new business unit that will harness...
Clinical Trials
Iddi intensifies global debate on the future of randomized...
International Drug Development Institute (IDDI), a leading therapy-focused Biostatistics and eClinical Services corporation based in Belgium with offices in Boston (MA) and Raleigh (NC) announces...
Clinical Trials
AIVITA Biomedical completes patient enrollment target in phase 2...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that it has reached its patient enrollment target in the company's phase...
Clinical Trials
Sanofis phase 2 study of BTK inhibitor, SAR442168 meets...
The Sanofi phase 2b study evaluating its investigational BTK (Brutons tyrosine kinase) inhibitor (SAR442168), an oral, brain-penetrant, selective small molecule, achieved its primary endpoint.
In the...
Clinical Trials
Teva Announces Positive Top-Line Results from AJOVY Clinical Trials...
Teva Pharmaceutical Industries Ltd announced positive results from two Phase 2/3 trials evaluating AJOVY® (fremanezumab) in patients in Japan. AJOVY is under development in Japan...
Clinical Trials
NeuroSense initiates clinical studies to evaluate benefit of PrimeC...
NeuroSense Therapeutics, a biotech company developing PrimeC, a combination drug which aims to slow or halt ALS progression, announced the initiation of two clinical studies...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.